ASHG 2026 · Tools, software & services
Helix at ASHG 2026
San Mateo, California
Helix at ASHG 2026 in Montréal: 8 presentations (5 posters, 2 platform talks, 1 plenary); Booth 1200.
8
presentations on the program
1200
exhibit booth
| Organization | ASHG 2026 Attendance |
|---|---|
Helix San Mateo, California | 2 Senior Research Scientist · 1 Medical Director · 1 Associate Director Research · 1 Senior Staff Scientist |
Helix sells population-scale genomic testing, clinico-genomic data, and research tools to health systems and life-science companies.
| Booth Exhibiting at Booth 1200 Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm Plenary Tue Oct 20 5:57 pm Population genomic screening for CDC Tier 1 conditions drives guideline-concordant care across 428,626 participants from 13 health systems Genetic testingPopulation geneticsClinical geneticsPrecision medicine Talk Wed Oct 21 11:45 am Distinct genetic architectures of kidney function decline quantified by multi-state Markov analysis of 3.4 million serial eGFR measurements across 13 health systems Complex traitsGenetic epidemiologyGenotype-phenotype correlationsPolygenic risk score Talk Thu Oct 22 1:45 pm Rare GLP1R variants selectively attenuate weight loss with semaglutide but not tirzepatide, implicating GIP receptor agonism as a compensatory mechanism PharmacogenomicsRare variantsObesityPrecision medicine Poster Thu Oct 22 4:15 pm APOE genotype shapes the trajectory from mild cognitive impairment to dementia in a large clinical genomics cohort NeurodegenerationElectronic health recordsGenotype-phenotype correlationsPrecision medicine Poster Thu Oct 22 4:15 pm ApoB isoform-specific mechanisms of liver disease in heterozygous pLoF carriers across three population cohorts Clinical geneticsGenetic variationLarge-scale biobanks Poster Fri Oct 23 2:30 pm Plasma proteomics highlights a preclinical cardiomyopathy signature in pathogenic variant carriers without clinical diagnosis Cardiovascular systemMachine learningProteomicsRare variants Poster Fri Oct 23 2:30 pm Plasma proteomic signatures of kidney disease within APOL1 genotype strata in a population genomic screening program Clinical testingGenetic testingMetabolic disorderPrecision medicine Poster Fri Oct 23 2:30 pm Cumulative pharmacogenomic variant burden associates with polypharmacy, treatment inefficacy, and adverse drug events PharmacogenomicsPharmacologic therapyGenetic variationGenotype-phenotype correlations |
Meeting Helix in Montréal?
Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction